BFM
ABMD

Boothbay Fund Management’s Abiomed Inc ABMD Stock Holding History

Boothbay Fund Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,361
Closed -$334K – 2677
2022
Q3 		$334K Buy
+1,361
New +$368K 0.01% 1457
2021
Q4 		– Sell
-1,128
Closed -$367K – 2371
2021
Q3 		$367K Buy
1,128
+273
+32% +$92.5K 0.01% 1231
2021
Q2 		$267K Buy
+855
New +$262K 0.01% 1356
2019
Q2 		– Sell
-712
Closed -$203K – 948
2019
Q1 		$203K Buy
+712
New +$237K 0.02% 609
2017
Q1 		– Sell
-2,521
Closed -$284 – 990
2016
Q4 		$284 Buy
+2,521
New +$292K 0.06% 417

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Boothbay Fund Management's ABMD Position: Q4 2022 in Review

Boothbay Fund Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,361 shares — an estimated $334K sold.

Boothbay Fund Management first reported a position in ABMD in Q4 2016 and held it in 5 quarters. The position peaked at $367K in Q3 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Boothbay Fund Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Boothbay Fund Management sold 1,361 Abiomed Inc shares in Q4 2022, an estimated $334K.
  • Boothbay Fund Management first reported a position in Abiomed Inc in Q4 2016 and held it in 5 quarters.
  • Boothbay Fund Management's Abiomed Inc position peaked at $367K in Q3 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Boothbay Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.